PRPF3
U4/U6 small nuclear ribonucleoprotein Prp3
Also known as: hPrp3, Prp3, PRPF3_HUMAN, RP18, SNRNP90
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O43395
- Gene
- PRPF3
- Ensembl
- ENSG00000117360
- Chromosome
- 1
- Canonical length
- 683 aa
- Protein class
- Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
The removal of introns from nuclear pre-mRNAs occurs on complexes called spliceosomes, which are made up of 4 small nuclear ribonucleoprotein (snRNP) particles and an undefined number of transiently associated splicing factors. This gene product is one of several proteins that associate with U4 and U6 snRNPs. Mutations in this gene are associated with retinitis pigmentosa-18. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
683 residues, UniProt reviewed canonical sequence.
>O43395|PRPF3
1 MALSKRELDE LKPWIEKTVK RVLGFSEPTV VTAALNCVGK GMDKKKAADH LKPFLDDSTL
61 RFVDKLFEAV EEGRSSRHSK SSSDRSRKRE LKEVFGDDSE ISKESSGVKK RRIPRFEEVE
121 EEPEVIPGPP SESPGMLTKL QIKQMMEAAT RQIEERKKQL SFISPPTPQP KTPSSSQPER
181 LPIGNTIQPS QAATFMNDAI EKARKAAELQ ARIQAQLALK PGLIGNANMV GLANLHAMGI
241 APPKVELKDQ TKPTPLILDE QGRTVDATGK EIELTHRMPT LKANIRAVKR EQFKQQLKEK
301 PSEDMESNTF FDPRVSIAPS QRQRRTFKFH DKGKFEKIAQ RLRTKAQLEK LQAEISQAAR
361 KTGIHTSTRL ALIAPKKELK EGDIPEIEWW DSYIIPNGFD LTEENPKRED YFGITNLVEH
421 PAQLNPPVDN DTPVTLGVYL TKKEQKKLRR QTRREAQKEL QEKVRLGLMP PPEPKVRISN
481 LMRVLGTEAV QDPTKVEAHV RAQMAKRQKA HEEANAARKL TAEQRKVKKI KKLKEDISQG
541 VHISVYRVRN LSNPAKKFKI EANAGQLYLT GVVVLHKDVN VVVVEGGPKA QKKFKRLMLH
601 RIKWDEQTSN TKGDDDEESD EEAVKKTNKC VLVWEGTAKD RSFGEMKFKQ CPTENMAREH
661 FKKHGAEHYW DLALSESVLE STDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PRPF3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.5
- Highest tissue expression
- 42 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 42 nTPM
- retina: 40 nTPM
- ovary: 34 nTPM
- spleen: 34 nTPM
- thyroid gland: 32 nTPM
- liver: 30 nTPM
Single-cell type
- neutrophil progenitors: 94 nCPM
- rod photoreceptor cells: 89 nCPM
- monocyte progenitors: 74 nCPM
- adrenal cortex cells: 65 nCPM
- medullary thymic epithelial cells: 62 nCPM
- early primary spermatocytes: 62 nCPM
Immune cell
- non-classical monocyte: 22 nTPM
- gdT-cell: 15 nTPM
- MAIT T-cell: 15 nTPM
- eosinophil: 13 nTPM
- memory B-cell: 13 nTPM
- intermediate monocyte: 12 nTPM
Brain region
- cerebellum: 33 nTPM
- choroid plexus: 33 nTPM
- hypothalamus: 30 nTPM
- white matter: 29 nTPM
- cerebral cortex: 28 nTPM
- basal ganglia: 27 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PRPF3.
Disease | AllUniProt
Conditions PRPF3 is implicated in, by any mechanism.
- Retinitis pigmentosa 18 (RP18) MIM:601414
Disease | GeneticClinVar
12 pathogenic / likely-pathogenic of 447 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Retinitis pigmentosa 18
- Retinal dystrophy
- Retinitis pigmentosa
- Retinitis pigmentosa 40
Disease | ImmuneIEDB
Conditions an epitope on PRPF3 was assayed in.
- ankylosing spondylitis T cell
- autoimmune uveitis T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.07
- gnomAD pLI
- 1
- gnomAD missense Z
- 3.85
- DepMap mean gene effect
- -0.86
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 12% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- mRNA processing
- mRNA splicing, via spliceosome
- RNA splicing
- RNA splicing, via transesterification reactions
- spliceosomal tri-snRNP complex assembly
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- PWI domain
- Small nuclear ribonucleoprotein Prp3, C-terminal domain
- PWI domain superfamily
- PWI domain
- Small nuclear ribonucleoprotein Prp3, C-terminal domain
- Pre-mRNA-splicing factor 3 domain
- U4/U6 small nuclear ribonucleoprotein Prp3
- pre-mRNA processing factor 3 domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PRPF3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PRPF3 as an antibody target. Whether an autoantibody or antibody against PRPF3 could matter depends on whether native PRPF3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PRPF3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PRPF3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...